[Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
D000368:Aged; D002216:Captopril / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010991:Plethysmography; D011392:Proline / Q000031:analogs & derivatives*; D013997:Time Factors
D011392:Proline; D002216:Captopril
Effets cliniques, hémodynamiques, pléthysmographiques et biologiques de l'inhibiteur oral de l'enzyme de conversion, captopril (SQ 14225), dans le traitement de l'insuffisance cardiaque congestive évoluée à court et moyem terme.